AI drug discovery: News, analysis and interviews

AI drug discovery is moving from science fiction to clinical reality — and the competitive stakes for biopharma have never been higher. Endpoints News has tracked this transformation from the earliest rounds: The AI-native biotechs building new pipelines from scratch, the big pharma partnerships placing billion-dollar bets on machine learning, and the foundational models — from AlphaFold to the latest virtual cell platforms — reshaping how drugs get designed. Our award-winning news reporting cuts through the hype to examine which companies are generating real clinical results and which deals are reshaping the field. The essential resource for biopharma professionals navigating the AI in biotech, AI in pharma and AI in drug R&D.

Top Stories

  1. Roche, Nvidia will build pharma's largest 'AI factory,' eclipsing Lilly's supercomputer

    • 3 months ago

  2. Isomorphic claims major advance with new AI drug design engine, in 'step change' versus AlphaFold 3

    • 4 months ago

  3. Isomorphic signs another pharma deal, partnering with J&J for AI-made drugs

    • 4 months ago

  4. Utah startup Leash Bio warns AI models could 'cheat' in biology. It bets its own 'dinky' model shows the way forward

    • 4 months ago

  5. Terray says its AI model beats a popular open-source model at predicting how molecules bind with proteins

    • 4 months ago

AI drug discovery: News, analysis and interviews Feed

  1. Alnylam signs its first AI discovery deal with RNA specialist Inceptive

    • Last week

  2. Bristol Myers turns focus to AI costs after broad rollout to workers

    • Last week

  3. Can AI do scientific research? Billions are pouring in to find out

    • 3 weeks ago

  4. How Utah’s AI prescribing experiment is going so far

    • 4 weeks ago

  5. Incyte signs AI deals with Genesis and Edison, tapping its experimental data

    • 4 weeks ago

  6. Five burning questions for Isomorphic after its mammoth $2B+ raise

    • Last month

  7. Exclusive: Knit Health raises $11.6M for 'fundamentally different' approach to healthcare AI

    • Last month

  8. ‘Pharma, not really’: Why AI’s top young talent isn’t interested in a career at big drugmakers

    • Last month

  9. CVS' healthcare delivery chief eyes potential in clinical AI

    • Last month

  10. Should pharma be swinging bigger with AI? One top researcher left Genentech so he could try

    • Last month

  11. AI keeps tackling harder targets in protein design, latest Adaptyv contest shows

    • Last month

  12. Exclusive: Fathom raises $47M, blending AI and physics in drug discovery

    • Last month

  13. OpenAI's head of health lays out the AI giant’s healthcare ambitions

    • Last month

  14. A closer look at Utah’s healthcare AI strategy

    • Last month

  15. UnitedHealth breaks down how it plans to spend $1.5B on AI

    • Last month

  16. Boehringer Ingelheim to expand its AI footprint in UK, in £150M investment

    • Last month

  17. OpenAI debuts a life sciences AI model, entering crowd of tech giants selling to pharma

    • 2 months ago

  18. Blurring the lines of healthcare AI

    • 2 months ago

  19. Scribing startup Abridge adds NEJM, JAMA as it moves into medical AI search

    • 2 months ago

  20. Tampa General's AI journey

    • 2 months ago

  21. Exclusive: China's Ailux adds AstraZeneca vet as CSO in hiring spree while eyeing clinic in 2027

    • 2 months ago

  22. China's Syneron raises $150M for peptides, adding to last year's $100M

    • 2 months ago

  23. A dog with cancer named Rosie ignites the latest debate between AI enthusiasts and biologists

    • 2 months ago

  24. Exclusive: In promising early readout, Enveda shows Dupixent-rivaling potential in atopic dermatitis

    • 2 months ago